Controversies in the Interpretation of Liquid Biopsy Data in Lymphoma

por Pirosa, Maria Cristina, Borchmann, Sven, Jardin, Fabrice, Gaidano, Gianluca, Rossi, Davide
Publicado 2022

Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study...

por Genta, Sofia, Ghilardi, Guido, Cascione, Luciano, Juskevicius, Darius, Tzankov, Alexandar, Schär, Sämi, Milan, Lisa, Pirosa, Maria Cristina, Esposito, Fabiana, Ruberto, Teresa, Giovanella, Luca, Hayoz, Stefanie, Mamot, Christoph, Dirnhofer, Stefan, Zucca, Emanuele, Ceriani, Luca
Publicado 2022

IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma

por Pirosa, Maria Cristina, Sassone, Marianna, Kiesewetter, Barbara, Guillermo, Armando Lopez, Devizzi, Liliana, Domènech, Eva Domingo, Tucci, Alessandra, Mannina, Donato, Merli, Michele, Salar, Antonio, Visco, Carlo, Esposito, Fabiana, Bonomini, Luisella, Zucca, Emanuele, Ferreri, Andrés J. M., Raderer, Markus
Publicado 2022

P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma

por Calabretta, Eleonora, Di Trani, Martina, Sollini, Martina, Ricci, Francesca, Corrado, Francesco, Cristaldi, Vanessa, Bonovas, Stefanos, Marino, Fabrizio, Mazza, Rita, Di Bergamo, Lodovico Terzi, Bruscaggin, Alessio, Pirosa, Maria Cristina, Bramanti, Stefania, Chiti, Arturo, Santoro, Armando, Rossi, Davide, Carlo-Stella, Carmelo
Publicado 2022